|
Category: natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Soluble in: |
| | water, 1.002e+005 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-mammal (species unspecified) LDLo 33 mg/kg Pharmacological Reviews. Vol. 22, Pg. 429, 1970.
intraperitoneal-mouse LD50 65 mg/kg Pharmazie. Vol. 49, Pg. 934, 1994.
intravenous-mouse LD50 59 mg/kg BLOOD: "LYMPHOMA, INCLUDING HODGKIN'S DISEASE"
LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE"
LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA Research Today. Vol. 5, Pg. 53, 1949.
intraperitoneal-rat LD50 34 mg/kg LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
LIVER: OTHER CHANGES Chemico-Biological Interactions. Vol. 5, Pg. 227, 1972.
intravenous-rat LD50 38 mg/kg LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
BLOOD: "LYMPHOMA, INCLUDING HODGKIN'S DISEASE"
LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" Research Today. Vol. 5, Pg. 53, 1949.
oral-rat LD50 34 mg/kg Xenobiotica. Vol. 1, Pg. 563, 1971.
unreported-rat LD50 35 mg/kg Cancer Research. Vol. 28, Pg. 2237, 1968.
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | natural substances and extractives |
| Recommendation for retrorsine usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for retrorsine flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
| European Food Safety Authority (EFSA) reference(s): |
Dietary exposure assessment to pyrrolizidine alkaloids in the European population View page or View pdf |
| EPI System: | View |
| Chemical Carcinogenesis Research Information System: | Search |
| Cancer Citations: | Search |
| Toxicology Citations: | Search |
| Carcinogenic Potency Database: | Search |
| EPA GENetic TOXicology: | Search |
| EPA ACToR: | Toxicology Data |
| EPA Substance Registry Services (SRS): | Registry |
| Laboratory Chemical Safety Summary : | 5281743 |
| National Institute of Allergy and Infectious Diseases: | Data |
| WGK Germany: | 3 |
| Chemidplus: | 0000480546 |
| RTECS: | VH7525000 for cas# 480-54-6 |
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| 12,18- | dihydroxy-senecionan-11,16-dione | | trans-15- | ethylidene-12b-hydroxy-12a-hydroxymethyl-13b-methylsenec-1-enine | | (3Z,5R,6S,14aR,14bR)-3- | ethylidene-6-hydroxy-6-(hydroxymethyl)-5-methyl-3,4,5,6,9,11,13,14,14a,14b-decahydro[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione | | beta- | longilobine | | | senecionan-11,16-dione, 12,18-dihydroxy- (9CI) |
Articles:
|